$CWBC
Community West Bancshares Stock $cwbc

$cwbc Overview Financials Valuation SEC Filings Company Website

2022 Q1 Form 10-Q Financial Statement

#000112737122000072 Filed on May 04, 2022

Income Statement

Concept	2022 Q1	2021 Q1
Revenue	$18.18M	$17.85M
YoY Change	1.88%	8.12%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$2.520M	$1.850M
YoY Change	36.22%	56.78%
% of Gross Profit
Operating Expenses
YoY Change
Operating Profit
YoY Change
Interest Expense	$585.0K	$292.0K
YoY Change	100.34%	-38.78%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income	$7.986M	$9.966M
YoY Change	-19.87%	9.31%
Income Tax	$1.900M	$2.487M
% Of Pretax Income	23.79%	24.95%
Net Earnings	$6.086M	$7.479M
YoY Change	-18.63%	12.92%
Net Earnings / Revenue	33.47%	41.91%
Basic Earnings Per Share	$0.51	$0.60
Diluted Earnings Per Share	$0.51	$0.60
COMMON SHARES
Basic Shares Outstanding	11.83M shares	12.50M shares
Diluted Shares Outstanding	11.87M shares	12.55M shares

Balance Sheet

Concept	2022 Q1	2021 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents	$88.84M	$214.8M
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment	$8.178M	$8.349M
YoY Change	-2.05%	12.67%
Goodwill	$53.78M	$53.78M
YoY Change	0.0%	0.0%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets
YoY Change
TOTAL ASSETS
Total Short-Term Assets
Total Long-Term Assets
Total Assets	$2.423B	$2.201B
YoY Change	10.11%	35.95%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$29.50M	$31.10M
YoY Change	-5.14%	-29.64%
Accrued Expenses	$4.900M
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$29.50M	$31.10M
YoY Change	-5.14%	-29.64%
LONG-TERM LIABILITIES
Long-Term Debt	$39.50M	$5.200M
YoY Change	659.62%	0.0%
Other Long-Term Liabilities	$11.10M	$16.70M
YoY Change	-33.53%	79.57%
Total Long-Term Liabilities	$39.50M	$5.200M
YoY Change	659.62%	0.0%
TOTAL LIABILITIES
Total Short-Term Liabilities	$29.50M	$31.10M
Total Long-Term Liabilities	$39.50M	$5.200M
Total Liabilities	$2.231B	$1.959B
YoY Change	13.92%	39.91%
SHAREHOLDERS EQUITY
Retained Earnings	$178.1M	$156.9M
YoY Change	13.52%	11.13%
Common Stock	$62.89M	$79.73M
YoY Change	-21.12%	1.11%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$191.7M	$241.8M
YoY Change
Total Liabilities & Shareholders Equity	$2.423B	$2.201B
YoY Change	10.11%	35.95%

Cashflow Statement

Concept	2022 Q1	2021 Q1
OPERATING ACTIVITIES
Net Income	$6.086M	$7.479M
YoY Change	-18.63%	12.92%
Depreciation, Depletion And Amortization	$2.520M	$1.850M
YoY Change	36.22%	56.78%
Cash From Operating Activities	-$635.0K	$6.379M
YoY Change	-109.95%	7.55%
INVESTING ACTIVITIES
Capital Expenditures	$2.000K	$344.0K
YoY Change	-99.42%	975.0%
Acquisitions
YoY Change
Other Investing Activities	-$107.8M	-$59.85M
YoY Change	80.17%	118.27%
Cash From Investing Activities	-$107.8M	-$60.19M
YoY Change	79.16%	119.24%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net	$4.486M	$0.00
YoY Change		-100.0%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	$33.84M	$198.4M
YoY Change	-82.94%	3781.3%
NET CHANGE
Cash From Operating Activities	-$635.0K	$6.379M
Cash From Investing Activities	-$107.8M	-$60.19M
Cash From Financing Activities	$33.84M	$198.4M
Net Change In Cash	-$74.63M	$144.6M
YoY Change	-151.62%	-980.84%
FREE CASH FLOW
Cash From Operating Activities	-$635.0K	$6.379M
Capital Expenditures	$2.000K	$344.0K
Free Cash Flow	-$637.0K	$6.035M
YoY Change	-110.56%	2.31%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2022Q1	dei	Entity Central Index Key EntityCentralIndexKey	0001127371
CY2022Q1	dei	Amendment Flag AmendmentFlag	false
CY2022Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2022Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2022
CY2022Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2022Q1	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2022Q1	us-gaap	Loans And Leases Receivable Allowance LoansAndLeasesReceivableAllowance	9864000	USD
CY2021Q4	us-gaap	Loans And Leases Receivable Allowance LoansAndLeasesReceivableAllowance	9600000	USD
CY2022Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2021Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2022Q1	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2021Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2022Q1	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2021Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2022Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	80000000	shares
CY2021Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	80000000	shares
CY2022Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	11752623	shares
CY2021Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	11916651	shares
CY2022Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	11752623	shares
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	11916651	shares
CY2022Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0
CY2021Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0
CY2022Q1	dei	Document Type DocumentType	10-Q
CY2022Q1	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2022Q1	dei	Document Period End Date DocumentPeriodEndDate	2022-03-31
CY2022Q1	dei	Document Transition Report DocumentTransitionReport	false
CY2022Q1	dei	Entity File Number EntityFileNumber	000-31977
CY2022Q1	dei	Entity Registrant Name EntityRegistrantName	CENTRAL VALLEY COMMUNITY BANCORP
CY2022Q1	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	CA
CY2022Q1	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	77-0539125
CY2022Q1	dei	Entity Address Address Line1 EntityAddressAddressLine1	7100 N. Financial Dr., Suite 101
CY2022Q1	dei	Entity Address City Or Town EntityAddressCityOrTown	Fresno
CY2022Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	382000	USD
CY2021Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	522000	USD
CY2022Q1	cvcy	Accrued Interest Receivable And Other Assets AccruedInterestReceivableAndOtherAssets	55461000	USD
CY2022Q1	dei	Entity Address State Or Province EntityAddressStateOrProvince	CA
CY2022Q1	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	93720
CY2022Q1	dei	City Area Code CityAreaCode	559
CY2022Q1	dei	Local Phone Number LocalPhoneNumber	298-1775
CY2022Q1	dei	Security12b Title Security12bTitle	Common Stock, no par value
CY2022Q1	dei	Trading Symbol TradingSymbol	CVCY
CY2022Q1	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2022Q1	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2022Q1	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2022Q1	dei	Entity Small Business EntitySmallBusiness	true
CY2022Q1	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2022Q1	dei	Entity Shell Company EntityShellCompany	false
CY2022Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	11658535	shares
CY2022Q1	us-gaap	Cash And Due From Banks CashAndDueFromBanks	32263000	USD
CY2021Q4	us-gaap	Cash And Due From Banks CashAndDueFromBanks	29412000	USD
CY2022Q1	us-gaap	Interest Bearing Deposits In Banks InterestBearingDepositsInBanks	56574000	USD
CY2021Q4	us-gaap	Interest Bearing Deposits In Banks InterestBearingDepositsInBanks	134055000	USD
CY2022Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	88837000	USD
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	163467000	USD
CY2022Q1	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	1161756000	USD
CY2021Q4	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	1109208000	USD
CY2022Q1	us-gaap	Equity Securities Fv Ni EquitySecuritiesFvNi	7071000	USD
CY2021Q4	us-gaap	Equity Securities Fv Ni EquitySecuritiesFvNi	7416000	USD
CY2022Q1	us-gaap	Loans And Leases Receivable Net Reported Amount LoansAndLeasesReceivableNetReportedAmount	1002178000	USD
CY2021Q4	us-gaap	Loans And Leases Receivable Net Reported Amount LoansAndLeasesReceivableNetReportedAmount	1029511000	USD
CY2022Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	8178000	USD
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	8380000	USD
CY2022Q1	us-gaap	Bank Owned Life Insurance BankOwnedLifeInsurance	39795000	USD
CY2021Q4	us-gaap	Bank Owned Life Insurance BankOwnedLifeInsurance	39553000	USD
CY2022Q1	us-gaap	Federal Home Loan Bank Stock FederalHomeLoanBankStock	5595000	USD
CY2021Q4	us-gaap	Federal Home Loan Bank Stock FederalHomeLoanBankStock	5595000	USD
CY2022Q1	us-gaap	Goodwill Goodwill	53777000	USD
CY2021Q4	us-gaap	Goodwill Goodwill	53777000	USD
CY2021Q4	cvcy	Accrued Interest Receivable And Other Assets AccruedInterestReceivableAndOtherAssets	32710000	USD
CY2022Q1	us-gaap	Assets Assets	2423030000	USD
CY2021Q4	us-gaap	Assets Assets	2450139000	USD
CY2022Q1	us-gaap	Noninterest Bearing Deposit Liabilities Domestic NoninterestBearingDepositLiabilitiesDomestic	926067000	USD
CY2021Q4	us-gaap	Noninterest Bearing Deposit Liabilities Domestic NoninterestBearingDepositLiabilitiesDomestic	963584000	USD
CY2022Q1	us-gaap	Interest Bearing Deposit Liabilities Domestic InterestBearingDepositLiabilitiesDomestic	1236293000	USD
CY2021Q4	us-gaap	Interest Bearing Deposit Liabilities Domestic InterestBearingDepositLiabilitiesDomestic	1159213000	USD
CY2022Q1	us-gaap	Deposits Deposits	2162360000	USD
CY2021Q4	us-gaap	Deposits Deposits	2122797000	USD
CY2022Q1	us-gaap	Junior Subordinated Debenture Owed To Unconsolidated Subsidiary Trust JuniorSubordinatedDebentureOwedToUnconsolidatedSubsidiaryTrust	39490000	USD
CY2021Q4	us-gaap	Junior Subordinated Debenture Owed To Unconsolidated Subsidiary Trust JuniorSubordinatedDebentureOwedToUnconsolidatedSubsidiaryTrust	39454000	USD
CY2022Q1	cvcy	Accrued Interest Payable And Other Liabilities AccruedInterestPayableAndOtherLiabilities	29520000	USD
CY2021Q4	cvcy	Accrued Interest Payable And Other Liabilities AccruedInterestPayableAndOtherLiabilities	40043000	USD
CY2022Q1	us-gaap	Liabilities Liabilities	2231370000	USD
CY2021Q4	us-gaap	Liabilities Liabilities	2202294000	USD
CY2022Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2021Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2022Q1	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2021Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2022Q1	us-gaap	Common Stock Value CommonStockValue	62893000	USD
CY2021Q4	us-gaap	Common Stock Value CommonStockValue	66820000	USD
CY2022Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	178054000	USD
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	173393000	USD
CY2022Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-49287000	USD
CY2021Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	7632000	USD
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	191660000	USD
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	247845000	USD
CY2022Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	2423030000	USD
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	2450139000	USD
CY2022Q1	us-gaap	Interest And Fee Income Loans And Leases InterestAndFeeIncomeLoansAndLeases	12161000	USD
CY2021Q1	us-gaap	Interest And Fee Income Loans And Leases InterestAndFeeIncomeLoansAndLeases	13765000	USD
CY2022Q1	us-gaap	Interest Income Deposits With Financial Institutions InterestIncomeDepositsWithFinancialInstitutions	57000	USD
CY2021Q1	us-gaap	Interest Income Deposits With Financial Institutions InterestIncomeDepositsWithFinancialInstitutions	32000	USD
CY2022Q1	us-gaap	Interest Income Securities Taxable InterestIncomeSecuritiesTaxable	4524000	USD
CY2021Q1	us-gaap	Interest Income Securities Taxable InterestIncomeSecuritiesTaxable	2733000	USD
CY2022Q1	us-gaap	Interest Income Securities Tax Exempt InterestIncomeSecuritiesTaxExempt	1440000	USD
CY2021Q1	us-gaap	Interest Income Securities Tax Exempt InterestIncomeSecuritiesTaxExempt	1317000	USD
CY2022Q1	us-gaap	Interest And Dividend Income Operating InterestAndDividendIncomeOperating	18182000	USD
CY2021Q1	us-gaap	Interest And Dividend Income Operating InterestAndDividendIncomeOperating	17847000	USD
CY2022Q1	us-gaap	Interest Expense Domestic Deposits InterestExpenseDomesticDeposits	252000	USD
CY2021Q1	us-gaap	Interest Expense Domestic Deposits InterestExpenseDomesticDeposits	268000	USD
CY2022Q1	us-gaap	Interest Expense Junior Subordinated Debentures InterestExpenseJuniorSubordinatedDebentures	333000	USD
CY2021Q1	us-gaap	Interest Expense Junior Subordinated Debentures InterestExpenseJuniorSubordinatedDebentures	24000	USD
CY2022Q1	us-gaap	Interest Expense InterestExpense	585000	USD
CY2021Q1	us-gaap	Interest Expense InterestExpense	292000	USD
CY2022Q1	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	17597000	USD
CY2021Q1	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	17555000	USD
CY2022Q1	us-gaap	Provision For Loan And Lease Losses ProvisionForLoanAndLeaseLosses	0	USD
CY2021Q1	us-gaap	Provision For Loan And Lease Losses ProvisionForLoanAndLeaseLosses	-1800000	USD
CY2022Q1	us-gaap	Interest Income Expense After Provision For Loan Loss InterestIncomeExpenseAfterProvisionForLoanLoss	17597000	USD
CY2021Q1	us-gaap	Interest Income Expense After Provision For Loan Loss InterestIncomeExpenseAfterProvisionForLoanLoss	19355000	USD
CY2022Q1	cvcy	Service Charges ServiceCharges	539000	USD
CY2021Q1	cvcy	Service Charges ServiceCharges	432000	USD
CY2022Q1	us-gaap	Bank Owned Life Insurance Income BankOwnedLifeInsuranceIncome	242000	USD
CY2021Q1	us-gaap	Bank Owned Life Insurance Income BankOwnedLifeInsuranceIncome	173000	USD
CY2022Q1	cvcy	Interchange Fees InterchangeFees	442000	USD
CY2021Q1	cvcy	Interchange Fees InterchangeFees	370000	USD
CY2022Q1	us-gaap	Debt And Equity Securities Gain Loss DebtAndEquitySecuritiesGainLoss	206000	USD
CY2021Q1	us-gaap	Debt And Equity Securities Gain Loss DebtAndEquitySecuritiesGainLoss	0	USD
CY2022Q1	cvcy	Dividends Federal Home Loan Bank Stocks DividendsFederalHomeLoanBankStocks	85000	USD
CY2021Q1	cvcy	Dividends Federal Home Loan Bank Stocks DividendsFederalHomeLoanBankStocks	70000	USD
CY2022Q1	cvcy	Loan Placement Fees LoanPlacementFees	299000	USD
CY2021Q1	cvcy	Loan Placement Fees LoanPlacementFees	657000	USD
CY2022Q1	us-gaap	Noninterest Income Other Operating Income NoninterestIncomeOtherOperatingIncome	21000	USD
CY2021Q1	us-gaap	Noninterest Income Other Operating Income NoninterestIncomeOtherOperatingIncome	297000	USD
CY2022Q1	us-gaap	Noninterest Income NoninterestIncome	1834000	USD
CY2021Q1	us-gaap	Noninterest Income NoninterestIncome	1999000	USD
CY2022Q1	us-gaap	Labor And Related Expense LaborAndRelatedExpense	6944000	USD
CY2021Q1	us-gaap	Labor And Related Expense LaborAndRelatedExpense	6938000	USD
CY2022Q1	us-gaap	Occupancy Net OccupancyNet	1162000	USD
CY2021Q1	us-gaap	Occupancy Net OccupancyNet	1113000	USD
CY2022Q1	us-gaap	Professional Fees ProfessionalFees	374000	USD
CY2021Q1	us-gaap	Professional Fees ProfessionalFees	356000	USD
CY2022Q1	us-gaap	Information Technology And Data Processing InformationTechnologyAndDataProcessing	541000	USD
CY2021Q1	us-gaap	Information Technology And Data Processing InformationTechnologyAndDataProcessing	617000	USD
CY2022Q1	cvcy	Regulatory Assessments RegulatoryAssessments	222000	USD
CY2021Q1	cvcy	Regulatory Assessments RegulatoryAssessments	161000	USD
CY2022Q1	cvcy	At Mand Debit Card Expenses ATMandDebitCardExpenses	195000	USD
CY2021Q1	cvcy	At Mand Debit Card Expenses ATMandDebitCardExpenses	225000	USD
CY2022Q1	cvcy	Information Technology InformationTechnology	758000	USD
CY2021Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	174000	USD
CY2022Q1	us-gaap	Other Noninterest Expense OtherNoninterestExpense	903000	USD
CY2021Q1	cvcy	Information Technology InformationTechnology	559000	USD
CY2022Q1	cvcy	Directors Expenses DirectorsExpenses	45000	USD
CY2021Q1	cvcy	Directors Expenses DirectorsExpenses	41000	USD
CY2022Q1	us-gaap	Advertising Expense AdvertisingExpense	140000	USD
CY2021Q1	us-gaap	Advertising Expense AdvertisingExpense	129000	USD
CY2022Q1	cvcy	Internet Banking Expense InternetBankingExpense	21000	USD
CY2021Q1	cvcy	Internet Banking Expense InternetBankingExpense	124000	USD
CY2022Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	140000	USD
CY2021Q1	us-gaap	Other Noninterest Expense OtherNoninterestExpense	951000	USD
CY2022Q1	us-gaap	Noninterest Expense NoninterestExpense	11445000	USD
CY2021Q1	us-gaap	Noninterest Expense NoninterestExpense	11388000	USD
CY2022Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	7986000	USD
CY2021Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	9966000	USD
CY2022Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1900000	USD
CY2021Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	2487000	USD
CY2022Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	6086000	USD
CY2021Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	7479000	USD
CY2022Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.51
CY2021Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.60
CY2022Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	11829245	shares
CY2021Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	12495606	shares
CY2022Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.51
CY2021Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.60
CY2022Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	11872025	shares
CY2021Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	12547137	shares
CY2022Q1	us-gaap	Common Stock Dividends Per Share Cash Paid CommonStockDividendsPerShareCashPaid	0.12
CY2021Q1	us-gaap	Common Stock Dividends Per Share Cash Paid CommonStockDividendsPerShareCashPaid	0.11
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	6086000	USD
	us-gaap	Net Income Loss NetIncomeLoss	7479000	USD
CY2022Q1	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax	-80603000	USD
CY2021Q1	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax	-13621000	USD
CY2022Q1	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Before Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax	206000	USD
CY2021Q1	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Before Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax	0	USD
CY2022Q1	us-gaap	Other Comprehensive Income Loss Before Tax OtherComprehensiveIncomeLossBeforeTax	-80809000	USD
CY2021Q1	us-gaap	Other Comprehensive Income Loss Before Tax OtherComprehensiveIncomeLossBeforeTax	-13621000	USD
CY2022Q1	us-gaap	Other Comprehensive Income Loss Tax OtherComprehensiveIncomeLossTax	-23890000	USD
CY2021Q1	us-gaap	Other Comprehensive Income Loss Tax OtherComprehensiveIncomeLossTax	-4027000	USD
CY2022Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-56919000	USD
CY2021Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-9594000	USD
CY2022Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-50833000	USD
CY2021Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-2115000	USD
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	245021000	USD
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	7479000	USD
CY2021Q1	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	-9594000	USD
CY2021Q1	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	56000	USD
CY2021Q1	us-gaap	Stock Issued During Period Value Employee Stock Ownership Plan StockIssuedDuringPeriodValueEmployeeStockOwnershipPlan	158000	USD
CY2021Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	101000	USD
CY2021Q1	us-gaap	Dividends Common Stock Cash DividendsCommonStockCash	1377000	USD
CY2021Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	1000	USD
CY2021Q1	us-gaap	Stockholders Equity StockholdersEquity	241845000	USD
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	247845000	USD
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	6086000	USD
CY2022Q1	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	-56919000	USD
CY2022Q1	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	57000	USD
CY2022Q1	us-gaap	Stock Issued During Period Value Employee Stock Ownership Plan StockIssuedDuringPeriodValueEmployeeStockOwnershipPlan	273000	USD
CY2022Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	97000	USD
CY2022Q1	us-gaap	Dividends Common Stock Cash DividendsCommonStockCash	1425000	USD
CY2022Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	132000	USD
CY2022Q1	us-gaap	Stock Repurchased And Retired During Period Value StockRepurchasedAndRetiredDuringPeriodValue	4486000	USD
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	191660000	USD
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	6086000	USD
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	7479000	USD
CY2022Q1	cvcy	Decrease Deferred Loan Costs DecreaseDeferredLoanCosts	-208000	USD
CY2021Q1	cvcy	Decrease Deferred Loan Costs DecreaseDeferredLoanCosts	559000	USD
CY2022Q1	us-gaap	Depreciation Nonproduction DepreciationNonproduction	204000	USD
CY2021Q1	us-gaap	Depreciation Nonproduction DepreciationNonproduction	223000	USD
CY2022Q1	cvcy	Accretion Amortizationof Discountsand Premiums AccretionAmortizationofDiscountsandPremiums	336000	USD
CY2021Q1	cvcy	Accretion Amortizationof Discountsand Premiums AccretionAmortizationofDiscountsandPremiums	327000	USD
CY2022Q1	us-gaap	Adjustment For Amortization AdjustmentForAmortization	2319000	USD
CY2021Q1	us-gaap	Adjustment For Amortization AdjustmentForAmortization	1633000	USD
CY2022Q1	us-gaap	Share Based Compensation ShareBasedCompensation	97000	USD
CY2021Q1	us-gaap	Share Based Compensation ShareBasedCompensation	101000	USD
CY2022Q1	us-gaap	Provision For Loan And Lease Losses ProvisionForLoanAndLeaseLosses	0	USD
CY2021Q1	us-gaap	Provision For Loan And Lease Losses ProvisionForLoanAndLeaseLosses	-1800000	USD
CY2022Q1	us-gaap	Debt Securities Available For Sale Realized Gain Loss DebtSecuritiesAvailableForSaleRealizedGainLoss	206000	USD
CY2021Q1	us-gaap	Debt Securities Available For Sale Realized Gain Loss DebtSecuritiesAvailableForSaleRealizedGainLoss	0	USD
CY2022Q1	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	0	USD
CY2021Q1	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	2000	USD
CY2021Q4	us-gaap	Debt Securities Available For Sale Accumulated Gross Unrealized Gain Loss Before Tax DebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedGainLossBeforeTax	10835000	USD
CY2022Q1	us-gaap	Increase Decrease In Trading Securities IncreaseDecreaseInTradingSecurities	-345000	USD
CY2021Q1	us-gaap	Increase Decrease In Trading Securities IncreaseDecreaseInTradingSecurities	-134000	USD
CY2022Q1	us-gaap	Life Insurance Corporate Or Bank Owned Change In Value LifeInsuranceCorporateOrBankOwnedChangeInValue	242000	USD
CY2021Q1	us-gaap	Life Insurance Corporate Or Bank Owned Change In Value LifeInsuranceCorporateOrBankOwnedChangeInValue	173000	USD
CY2022Q1	cvcy	Increase Decrease In Accrued Interest Receivable And Other Operating Assets Net IncreaseDecreaseInAccruedInterestReceivableAndOtherOperatingAssetsNet	-1574000	USD
CY2021Q1	cvcy	Increase Decrease In Accrued Interest Receivable And Other Operating Assets Net IncreaseDecreaseInAccruedInterestReceivableAndOtherOperatingAssetsNet	504000	USD
CY2022Q1	cvcy	Increase Decrease In Interest Payable And Other Operating Liabilities Net IncreaseDecreaseInInterestPayableAndOtherOperatingLiabilitiesNet	-10249000	USD
CY2021Q1	cvcy	Increase Decrease In Interest Payable And Other Operating Liabilities Net IncreaseDecreaseInInterestPayableAndOtherOperatingLiabilitiesNet	69000	USD
CY2022Q1	us-gaap	Increase Decrease In Deferred Income Taxes IncreaseDecreaseInDeferredIncomeTaxes	435000	USD
CY2021Q1	us-gaap	Increase Decrease In Deferred Income Taxes IncreaseDecreaseInDeferredIncomeTaxes	-105000	USD
CY2022Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-635000	USD
CY2021Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	6379000	USD
CY2022Q1	us-gaap	Payments To Acquire Available For Sale Securities Debt PaymentsToAcquireAvailableForSaleSecuritiesDebt	286385000	USD
CY2021Q1	us-gaap	Payments To Acquire Available For Sale Securities Debt PaymentsToAcquireAvailableForSaleSecuritiesDebt	84685000	USD
CY2022Q1	us-gaap	Proceeds From Sale Of Available For Sale Securities Debt ProceedsFromSaleOfAvailableForSaleSecuritiesDebt	132991000	USD
CY2021Q1	us-gaap	Proceeds From Sale Of Available For Sale Securities Debt ProceedsFromSaleOfAvailableForSaleSecuritiesDebt	0	USD
CY2022Q1	us-gaap	Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities	18435000	USD
CY2021Q1	us-gaap	Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities	11331000	USD
CY2022Q1	us-gaap	Payments For Proceeds From Loans And Leases PaymentsForProceedsFromLoansAndLeases	-27125000	USD
CY2021Q1	us-gaap	Payments For Proceeds From Loans And Leases PaymentsForProceedsFromLoansAndLeases	-13507000	USD
CY2022Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	2000	USD
CY2021Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	344000	USD
CY2022Q1	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	0	USD
CY2021Q1	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	2000	USD
CY2022Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-107836000	USD
CY2021Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-60189000	USD
CY2022Q1	cvcy	Net Increase Decrease In Demand Interest Bearing And Savings Deposits NetIncreaseDecreaseInDemandInterestBearingAndSavingsDeposits	44891000	USD
CY2021Q1	cvcy	Net Increase Decrease In Demand Interest Bearing And Savings Deposits NetIncreaseDecreaseInDemandInterestBearingAndSavingsDeposits	200112000	USD
CY2022Q1	us-gaap	Increase Decrease In Time Deposits IncreaseDecreaseInTimeDeposits	-5328000	USD
CY2021Q1	us-gaap	Increase Decrease In Time Deposits IncreaseDecreaseInTimeDeposits	-419000	USD
CY2022Q1	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	4486000	USD
CY2021Q1	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	0	USD
CY2022Q1	us-gaap	Proceeds From Stock Plans ProceedsFromStockPlans	57000	USD
CY2021Q1	us-gaap	Proceeds From Stock Plans ProceedsFromStockPlans	56000	USD
CY2022Q1	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	132000	USD
CY2021Q1	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	1000	USD
CY2022Q1	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	1425000	USD
CY2021Q1	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	1377000	USD
CY2022Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	33841000	USD
CY2021Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	198373000	USD
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-74630000	USD
CY2021Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	144563000	USD
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	163467000	USD
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	70278000	USD
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	88837000	USD
CY2021Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	214841000	USD
CY2022Q1	us-gaap	Interest Paid Net InterestPaidNet	172000	USD
CY2021Q1	us-gaap	Interest Paid Net InterestPaidNet	298000	USD
CY2022Q1	us-gaap	Operating Lease Payments OperatingLeasePayments	575000	USD
CY2021Q1	us-gaap	Operating Lease Payments OperatingLeasePayments	562000	USD
CY2022Q1	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	No customer accounts for more than 10 percent of revenues for the Company or the Bank.
CY2022Q1	us-gaap	Pledged Assets Separately Reported Securities Pledged As Collateral At Fair Value PledgedAssetsSeparatelyReportedSecuritiesPledgedAsCollateralAtFairValue	223954000	USD
CY2022Q1	us-gaap	Debt Securities Available For Sale Accumulated Gross Unrealized Gain Loss Before Tax DebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedGainLossBeforeTax	-69974000	USD
CY2022Q1	cvcy	Accumulated Other Comprehensive Income Available For Sale Securities Adjustment Tax AccumulatedOtherComprehensiveIncomeAvailableForSaleSecuritiesAdjustmentTax	-20687000	USD
CY2021Q4	cvcy	Accumulated Other Comprehensive Income Available For Sale Securities Adjustment Tax AccumulatedOtherComprehensiveIncomeAvailableForSaleSecuritiesAdjustmentTax	3203000	USD
CY2022Q1	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	1231730000	USD
CY2022Q1	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	2385000	USD
CY2022Q1	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	72359000	USD
CY2022Q1	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	1161756000	USD
CY2021Q4	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	1098373000	USD
CY2021Q4	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	20373000	USD
CY2021Q4	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	9538000	USD
CY2021Q4	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	1109208000	USD
CY2022Q1	us-gaap	Proceeds From Sale Of Available For Sale Securities Debt ProceedsFromSaleOfAvailableForSaleSecuritiesDebt	132991000	USD
CY2021Q1	us-gaap	Proceeds From Sale Of Available For Sale Securities Debt ProceedsFromSaleOfAvailableForSaleSecuritiesDebt	0	USD
CY2022Q1	us-gaap	Debt Securities Available For Sale Realized Gain DebtSecuritiesAvailableForSaleRealizedGain	206000	USD
CY2022Q1	cvcy	Threshold Percentage Of Value Decline In Available For Sale Securities To Be Considered Other Than Temporary Impairment ThresholdPercentageOfValueDeclineInAvailableForSaleSecuritiesToBeConsideredOtherThanTemporaryImpairment	0.10
CY2022Q1	cvcy	Threshold Amount Of Value Decline In Available For Sale Securities To Be Considered Other Than Temporary Impairment ThresholdAmountOfValueDeclineInAvailableForSaleSecuritiesToBeConsideredOtherThanTemporaryImpairment	75000	USD
CY2022Q1	us-gaap	Impairment Of Investments ImpairmentOfInvestments	0	USD
CY2021Q1	us-gaap	Debt Securities Available For Sale Realized Gain DebtSecuritiesAvailableForSaleRealizedGain	0	USD
CY2022Q1	us-gaap	Debt Securities Available For Sale Realized Loss DebtSecuritiesAvailableForSaleRealizedLoss	0	USD
CY2021Q1	us-gaap	Debt Securities Available For Sale Realized Loss DebtSecuritiesAvailableForSaleRealizedLoss	0	USD
CY2022Q1	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesTax	61000	USD
CY2022Q1	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months	926452000	USD
CY2022Q1	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss	62862000	USD
CY2022Q1	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger	115013000	USD
CY2022Q1	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss	9497000	USD
CY2022Q1	us-gaap	Debt Securities Available For Sale Unrealized Loss Position DebtSecuritiesAvailableForSaleUnrealizedLossPosition	1041465000	USD
CY2022Q1	us-gaap	Debt Securities Available For Sale Unrealized Loss Position Accumulated Loss DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss	72359000	USD
CY2021Q4	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months	496816000	USD
CY2021Q4	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss	7842000	USD
CY2021Q4	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger	75609000	USD
CY2021Q4	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss	1696000	USD
CY2021Q4	us-gaap	Debt Securities Available For Sale Unrealized Loss Position DebtSecuritiesAvailableForSaleUnrealizedLossPosition	572425000	USD
CY2021Q4	us-gaap	Debt Securities Available For Sale Unrealized Loss Position Accumulated Loss DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss	9538000	USD
CY2022Q1	cvcy	Threshold Period Of Value Decline In Available For Sale Securities To Be Considered Other Than Temporary Impairment ThresholdPeriodOfValueDeclineInAvailableForSaleSecuritiesToBeConsideredOtherThanTemporaryImpairment	P12M
CY2022Q1	cvcy	Available For Sale Securities Number Of Securities Loss Position AvailableForSaleSecuritiesNumberOfSecuritiesLossPosition	11	Loans
CY2022Q1	us-gaap	Available For Sale Securities Debt Maturities Within One Year Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost	0	USD
CY2022Q1	us-gaap	Available For Sale Securities Debt Maturities Within One Year Fair Value AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue	0	USD
CY2022Q1	us-gaap	Available For Sale Securities Debt Maturities After One Through Five Years Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost	3727000	USD
CY2022Q1	us-gaap	Available For Sale Securities Debt Maturities After One Through Five Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue	3877000	USD
CY2022Q1	us-gaap	Available For Sale Securities Debt Maturities After Five Through Ten Years Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost	98715000	USD
CY2022Q1	us-gaap	Available For Sale Securities Debt Maturities After Five Through Ten Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue	92825000	USD
CY2022Q1	us-gaap	Available For Sale Securities Debt Maturities After Ten Years Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost	346536000	USD
CY2022Q1	us-gaap	Available For Sale Securities Debt Maturities After Ten Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue	321685000	USD
CY2022Q1	cvcy	Available For Sale Securities Debt Maturities With Single Maturity Date Amortized Cost Basis AvailableForSaleSecuritiesDebtMaturitiesWithSingleMaturityDateAmortizedCostBasis	448978000	USD
CY2022Q1	cvcy	Available For Sale Securities Debt Maturities With Single Maturity Date Fair Value AvailableForSaleSecuritiesDebtMaturitiesWithSingleMaturityDateFairValue	418387000	USD
CY2022Q1	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	1231730000	USD
CY2022Q1	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	1161756000	USD
CY2022Q1	us-gaap	Unamortized Loan Commitment And Origination Fees And Unamortized Discounts Or Premiums UnamortizedLoanCommitmentAndOriginationFeesAndUnamortizedDiscountsOrPremiums	1079000	USD
CY2021Q4	us-gaap	Unamortized Loan Commitment And Origination Fees And Unamortized Discounts Or Premiums UnamortizedLoanCommitmentAndOriginationFeesAndUnamortizedDiscountsOrPremiums	871000	USD
CY2022Q1	us-gaap	Loans And Leases Receivable Gross Carrying Amount LoansAndLeasesReceivableGrossCarryingAmount	1012042000	USD
CY2022Q1	cvcy	Loans And Leases Receivable Percentage Of Gross Loans LoansAndLeasesReceivablePercentageOfGrossLoans	1.000
CY2021Q4	us-gaap	Loans And Leases Receivable Gross Carrying Amount LoansAndLeasesReceivableGrossCarryingAmount	1039111000	USD
CY2021Q4	cvcy	Loans And Leases Receivable Percentage Of Gross Loans LoansAndLeasesReceivablePercentageOfGrossLoans	1.000
CY2022Q1	us-gaap	Loans And Leases Receivable Allowance LoansAndLeasesReceivableAllowance	9864000	USD
CY2021Q4	us-gaap	Loans And Leases Receivable Allowance LoansAndLeasesReceivableAllowance	9600000	USD
CY2022Q1	us-gaap	Loans And Leases Receivable Net Reported Amount LoansAndLeasesReceivableNetReportedAmount	1002178000	USD
CY2021Q4	us-gaap	Loans And Leases Receivable Net Reported Amount LoansAndLeasesReceivableNetReportedAmount	1029511000	USD
CY2022Q1	cvcy	Loansand Leases Receivable Allowance Numberof Components LoansandLeasesReceivableAllowanceNumberofComponents	2	component
CY2022Q1	cvcy	Financing Receivable Allowance For Credit Losses Methodology Change Number Of Rolling Quarters Used In Analysis FinancingReceivableAllowanceForCreditLossesMethodologyChangeNumberOfRollingQuartersUsedInAnalysis	53	quarter
CY2021Q4	us-gaap	Financing Receivable Allowance For Credit Losses FinancingReceivableAllowanceForCreditLosses	9600000	USD
CY2022Q1	us-gaap	Provision For Loan Lease And Other Losses ProvisionForLoanLeaseAndOtherLosses	0	USD
CY2022Q1	us-gaap	Financing Receivable Allowance For Credit Losses Write Offs FinancingReceivableAllowanceForCreditLossesWriteOffs	101000	USD
CY2022Q1	us-gaap	Financing Receivable Allowance For Credit Losses Recovery FinancingReceivableAllowanceForCreditLossesRecovery	365000	USD
CY2022Q1	us-gaap	Financing Receivable Allowance For Credit Losses FinancingReceivableAllowanceForCreditLosses	9864000	USD
CY2020Q4	us-gaap	Financing Receivable Allowance For Credit Losses FinancingReceivableAllowanceForCreditLosses	12915000	USD
CY2021Q1	us-gaap	Provision For Loan Lease And Other Losses ProvisionForLoanLeaseAndOtherLosses	1800000	USD
CY2021Q1	us-gaap	Financing Receivable Allowance For Credit Losses Write Offs FinancingReceivableAllowanceForCreditLossesWriteOffs	57000	USD
CY2021Q1	us-gaap	Financing Receivable Allowance For Credit Losses Recovery FinancingReceivableAllowanceForCreditLossesRecovery	998000	USD
CY2021Q1	us-gaap	Financing Receivable Allowance For Credit Losses FinancingReceivableAllowanceForCreditLosses	12056000	USD
CY2022Q1	us-gaap	Financing Receivable Allowance For Credit Losses FinancingReceivableAllowanceForCreditLosses	9864000	USD
CY2022Q1	us-gaap	Financing Receivable Allowance For Credit Losses Individually Evaluated For Impairment1 FinancingReceivableAllowanceForCreditLossesIndividuallyEvaluatedForImpairment1	583000	USD
CY2022Q1	us-gaap	Financing Receivable Allowance For Credit Losses Collectively Evaluated For Impairment FinancingReceivableAllowanceForCreditLossesCollectivelyEvaluatedForImpairment	9281000	USD
CY2021Q4	us-gaap	Financing Receivable Allowance For Credit Losses FinancingReceivableAllowanceForCreditLosses	9600000	USD
CY2021Q4	us-gaap	Financing Receivable Allowance For Credit Losses Individually Evaluated For Impairment1 FinancingReceivableAllowanceForCreditLossesIndividuallyEvaluatedForImpairment1	649000	USD
CY2021Q4	us-gaap	Financing Receivable Allowance For Credit Losses Collectively Evaluated For Impairment FinancingReceivableAllowanceForCreditLossesCollectivelyEvaluatedForImpairment	8951000	USD
CY2022Q1	us-gaap	Notes Receivable Gross NotesReceivableGross	1010963000	USD
CY2022Q1	us-gaap	Financing Receivable Individually Evaluated For Impairment FinancingReceivableIndividuallyEvaluatedForImpairment	3759000	USD
CY2022Q1	us-gaap	Financing Receivable Collectively Evaluated For Impairment FinancingReceivableCollectivelyEvaluatedForImpairment	1007204000	USD
CY2021Q4	us-gaap	Notes Receivable Gross NotesReceivableGross	1038240000	USD
CY2021Q4	us-gaap	Financing Receivable Individually Evaluated For Impairment FinancingReceivableIndividuallyEvaluatedForImpairment	8586000	USD
CY2021Q4	us-gaap	Financing Receivable Collectively Evaluated For Impairment FinancingReceivableCollectivelyEvaluatedForImpairment	1029654000	USD
CY2022Q1	us-gaap	Notes Receivable Gross NotesReceivableGross	1010963000	USD
CY2021Q4	us-gaap	Notes Receivable Gross NotesReceivableGross	1038240000	USD
CY2022Q1	us-gaap	Notes Receivable Gross NotesReceivableGross	1010963000	USD
CY2022Q1	us-gaap	Financing Receivable Recorded Investment90 Days Past Due And Still Accruing FinancingReceivableRecordedInvestment90DaysPastDueAndStillAccruing	0	USD
CY2022Q1	us-gaap	Financing Receivable Recorded Investment Nonaccrual Status FinancingReceivableRecordedInvestmentNonaccrualStatus	292000	USD
CY2021Q4	us-gaap	Notes Receivable Gross NotesReceivableGross	1038240000	USD
CY2021Q4	us-gaap	Financing Receivable Recorded Investment90 Days Past Due And Still Accruing FinancingReceivableRecordedInvestment90DaysPastDueAndStillAccruing	0	USD
CY2021Q4	us-gaap	Financing Receivable Recorded Investment Nonaccrual Status FinancingReceivableRecordedInvestmentNonaccrualStatus	946000	USD
CY2022Q1	us-gaap	Impaired Financing Receivable With No Related Allowance Recorded Investment ImpairedFinancingReceivableWithNoRelatedAllowanceRecordedInvestment	135000	USD
CY2022Q1	us-gaap	Impaired Financing Receivable With No Related Allowance Unpaid Principal Balance ImpairedFinancingReceivableWithNoRelatedAllowanceUnpaidPrincipalBalance	170000	USD
CY2022Q1	us-gaap	Impaired Financing Receivable With Related Allowance Recorded Investment ImpairedFinancingReceivableWithRelatedAllowanceRecordedInvestment	3624000	USD
CY2022Q1	us-gaap	Impaired Financing Receivable With Related Allowance Unpaid Principal Balance ImpairedFinancingReceivableWithRelatedAllowanceUnpaidPrincipalBalance	3669000	USD
CY2022Q1	us-gaap	Impaired Financing Receivable Related Allowance ImpairedFinancingReceivableRelatedAllowance	583000	USD
CY2022Q1	us-gaap	Impaired Financing Receivable Recorded Investment ImpairedFinancingReceivableRecordedInvestment	3759000	USD
CY2022Q1	us-gaap	Impaired Financing Receivable Unpaid Principal Balance ImpairedFinancingReceivableUnpaidPrincipalBalance	3839000	USD
CY2022Q1	us-gaap	Impaired Financing Receivable Related Allowance ImpairedFinancingReceivableRelatedAllowance	583000	USD
CY2021Q4	us-gaap	Impaired Financing Receivable With No Related Allowance Recorded Investment ImpairedFinancingReceivableWithNoRelatedAllowanceRecordedInvestment	136000	USD
CY2021Q4	us-gaap	Impaired Financing Receivable With No Related Allowance Unpaid Principal Balance ImpairedFinancingReceivableWithNoRelatedAllowanceUnpaidPrincipalBalance	172000	USD
CY2021Q4	us-gaap	Impaired Financing Receivable With Related Allowance Recorded Investment ImpairedFinancingReceivableWithRelatedAllowanceRecordedInvestment	8450000	USD
CY2021Q4	us-gaap	Impaired Financing Receivable With Related Allowance Unpaid Principal Balance ImpairedFinancingReceivableWithRelatedAllowanceUnpaidPrincipalBalance	8570000	USD
CY2021Q4	us-gaap	Impaired Financing Receivable Related Allowance ImpairedFinancingReceivableRelatedAllowance	649000	USD
CY2021Q1	us-gaap	Loans And Leases Receivable Impaired Interest Lost On Nonaccrual Loans LoansAndLeasesReceivableImpairedInterestLostOnNonaccrualLoans	56000	USD
CY2021Q4	us-gaap	Impaired Financing Receivable Recorded Investment ImpairedFinancingReceivableRecordedInvestment	8586000	USD
CY2021Q4	us-gaap	Impaired Financing Receivable Unpaid Principal Balance ImpairedFinancingReceivableUnpaidPrincipalBalance	8742000	USD
CY2021Q4	us-gaap	Impaired Financing Receivable Related Allowance ImpairedFinancingReceivableRelatedAllowance	649000	USD
CY2022Q1	us-gaap	Impaired Financing Receivable With No Related Allowance Average Recorded Investment ImpairedFinancingReceivableWithNoRelatedAllowanceAverageRecordedInvestment	362000	USD
CY2022Q1	us-gaap	Impaired Financing Receivable With No Related Allowance Interest Income Accrual Method ImpairedFinancingReceivableWithNoRelatedAllowanceInterestIncomeAccrualMethod	3000	USD
CY2021Q1	us-gaap	Impaired Financing Receivable With No Related Allowance Average Recorded Investment ImpairedFinancingReceivableWithNoRelatedAllowanceAverageRecordedInvestment	952000	USD
CY2021Q1	us-gaap	Impaired Financing Receivable With No Related Allowance Interest Income Accrual Method ImpairedFinancingReceivableWithNoRelatedAllowanceInterestIncomeAccrualMethod	12000	USD
CY2022Q1	us-gaap	Impaired Financing Receivable With Related Allowance Average Recorded Investment ImpairedFinancingReceivableWithRelatedAllowanceAverageRecordedInvestment	4841000	USD
CY2022Q1	us-gaap	Impaired Financing Receivable With Related Allowance Interest Income Accrual Method ImpairedFinancingReceivableWithRelatedAllowanceInterestIncomeAccrualMethod	47000	USD
CY2021Q1	us-gaap	Impaired Financing Receivable With Related Allowance Average Recorded Investment ImpairedFinancingReceivableWithRelatedAllowanceAverageRecordedInvestment	10386000	USD
CY2021Q1	us-gaap	Impaired Financing Receivable With Related Allowance Interest Income Accrual Method ImpairedFinancingReceivableWithRelatedAllowanceInterestIncomeAccrualMethod	650000	USD
CY2022Q1	us-gaap	Impaired Financing Receivable Average Recorded Investment ImpairedFinancingReceivableAverageRecordedInvestment	5203000	USD
CY2022Q1	us-gaap	Impaired Financing Receivable Interest Income Accrual Method ImpairedFinancingReceivableInterestIncomeAccrualMethod	50000	USD
CY2021Q1	us-gaap	Impaired Financing Receivable Average Recorded Investment ImpairedFinancingReceivableAverageRecordedInvestment	11338000	USD
CY2021Q1	us-gaap	Impaired Financing Receivable Interest Income Accrual Method ImpairedFinancingReceivableInterestIncomeAccrualMethod	662000	USD
CY2022Q1	us-gaap	Loans And Leases Receivable Impaired Interest Lost On Nonaccrual Loans LoansAndLeasesReceivableImpairedInterestLostOnNonaccrualLoans	4000	USD
CY2021Q1	cvcy	Financing Receivable Modifications Subsequent Defaults During Period Number Of Contracts FinancingReceivableModificationsSubsequentDefaultsDuringPeriodNumberOfContracts	0	contract
CY2022Q1	cvcy	Financing Receivable Modifications Subsequent Defaults During Period Number Of Contracts FinancingReceivableModificationsSubsequentDefaultsDuringPeriodNumberOfContracts	0	contract
CY2022Q1	us-gaap	Financing Receivable Modifications Recorded Investment FinancingReceivableModificationsRecordedInvestment	3467000	USD
CY2021Q4	us-gaap	Financing Receivable Modifications Recorded Investment FinancingReceivableModificationsRecordedInvestment	7640000	USD
CY2022Q1	cvcy	Financing Receivable Modifications Related Allowance FinancingReceivableModificationsRelatedAllowance	543000	USD
CY2021Q4	cvcy	Financing Receivable Modifications Related Allowance FinancingReceivableModificationsRelatedAllowance	538000	USD
CY2022Q1	us-gaap	Goodwill Goodwill	53777000	USD
CY2021Q4	us-gaap	Federal Funds Purchased FederalFundsPurchased	0	USD
CY2022Q1	us-gaap	Federal Funds Purchased FederalFundsPurchased	0	USD
CY2022Q1	cvcy	Amount Of Trust Preferred Securities Eligible As Tier One Capital Maximum Percentage AmountOfTrustPreferredSecuritiesEligibleAsTierOneCapitalMaximumPercentage	0.25
CY2022Q1	us-gaap	Debt Instrument Basis Spread On Variable Rate1 DebtInstrumentBasisSpreadOnVariableRate1	0.0160
CY2022Q1	cvcy	Long Term Debt Terms Redemption Period LongTermDebtTermsRedemptionPeriod	P90D
CY2022Q1	cvcy	Percentage Of Aggregate Principal Amount Of Notes Outstanding Required To Call Notes PercentageOfAggregatePrincipalAmountOfNotesOutstandingRequiredToCallNotes	0.25
CY2022Q1	cvcy	Number Of Consecutive Quarterly Periods Of Nonpayment Required To Call Notes NumberOfConsecutiveQuarterlyPeriodsOfNonpaymentRequiredToCallNotes	20	quarter
CY2022Q1	cvcy	Trust Preferred Securities Liquidation Value Per Unit TrustPreferredSecuritiesLiquidationValuePerUnit	1000
CY2022Q1	us-gaap	Debt Instrument Basis Spread On Variable Rate1 DebtInstrumentBasisSpreadOnVariableRate1	0.0160
CY2022Q1	us-gaap	Debt Instrument Interest Rate Stated Percentage DebtInstrumentInterestRateStatedPercentage	0.0184
CY2022Q1	us-gaap	Interest Expense Trust Preferred Securities InterestExpenseTrustPreferredSecurities	333000	USD
CY2021Q1	us-gaap	Interest Expense Trust Preferred Securities InterestExpenseTrustPreferredSecurities	24000	USD
CY2022Q1	us-gaap	Other Commitment OtherCommitment	2144500	USD
CY2022Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	6086000	USD
CY2021Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	7479000	USD
CY2022Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	11829245	shares
CY2021Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	12495606	shares
CY2022Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.51
CY2021Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.60
CY2022Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	6086000	USD
CY2021Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	7479000	USD
CY2022Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	11829245	shares
CY2021Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	12495606	shares
CY2022Q1	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants	42780	shares
CY2021Q1	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants	51531	shares
CY2022Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	11872025	shares
CY2021Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	12547137	shares
CY2022Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.51
CY2021Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.60
CY2021Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	0	shares
CY2022Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	0	shares
CY2022Q1	cvcy	Sharebased Compensation Arrangementby Sharebased Payment Award Numberof Plans SharebasedCompensationArrangementbySharebasedPaymentAwardNumberofPlans	4	plan
CY2022Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	97000	USD
CY2021Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	101000	USD
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	0	shares
CY2021Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	0	shares
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	52805	shares
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	9.81
CY2022Q1	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	11075	shares
CY2022Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	11.87
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod	1800	shares
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice	12.50
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	39930	shares
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	9.12
CY2022Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P0Y4M17D
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	566000	USD
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber	39930	shares
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice	9.12
CY2022Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1	P0Y4M17D
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue	566000	USD
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber	39930	shares
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice	9.12
CY2022Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1	P0Y4M17D
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue	566000	USD
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	118000	USD
CY2021Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	1000	USD
CY2022Q1	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	132000	USD
CY2021Q1	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	1000	USD
CY2022Q1	us-gaap	Employee Service Share Based Compensation Tax Benefit From Exercise Of Stock Options EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions	22000	USD
CY2021Q1	us-gaap	Employee Service Share Based Compensation Tax Benefit From Exercise Of Stock Options EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions	0	USD
CY2022Q1	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions	0	USD

Files In Submission

Name	View Source	Status
0001127371-22-000072-index-headers.html	Edgar Link	pending
0001127371-22-000072-index.html	Edgar Link	pending
0001127371-22-000072.txt	Edgar Link	pending
0001127371-22-000072-xbrl.zip	Edgar Link	pending
cvcy-20220331.htm	Edgar Link	pending
cvcy-20220331.xsd	Edgar Link	pending
cvcy-20220331_cal.xml	Edgar Link	unprocessable
cvcy-20220331_def.xml	Edgar Link	unprocessable
cvcy-20220331_htm.xml	Edgar Link	completed
cvcy-20220331_lab.xml	Edgar Link	unprocessable
cvcy-20220331_pre.xml	Edgar Link	unprocessable
exhibit3112022q1-ng.htm	Edgar Link	pending
exhibit3122022q1-ng.htm	Edgar Link	pending
exhibit3212022q1-ng.htm	Edgar Link	pending
exhibit3222022q1-ng.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$CWBC
Community West Bancshares Stock $cwbc

2022 Q1 Form 10-Q Financial Statement

#000112737122000072 Filed on May 04, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CWBC Community West Bancshares Stock $cwbc

2022 Q1 Form 10-Q Financial Statement

#000112737122000072 Filed on May 04, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CWBC
Community West Bancshares Stock $cwbc